262 related articles for article (PubMed ID: 9349235)
1. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
J Pathol; 1997 Jul; 182(3):318-24. PubMed ID: 9349235
[TBL] [Abstract][Full Text] [Related]
2. Comparison of classic and quantitative prognostic factors in colorectal cancer.
Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
4. A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Lipponen P; Vesalainen S; Kasurinen J; Ala-Opas M; Syrjänen K
Anticancer Res; 1996; 16(4A):2095-100. PubMed ID: 8712749
[TBL] [Abstract][Full Text] [Related]
5. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
[TBL] [Abstract][Full Text] [Related]
6. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors in colorectal neoplasm. Multivariate analysis in 224 patients].
Bannura G; Cumsille MA; Contreras J; Melo C; Barrera A; Reinero M; Pardo L
Rev Med Chil; 2001 Mar; 129(3):237-46. PubMed ID: 11372289
[TBL] [Abstract][Full Text] [Related]
8. Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy.
Kärjä V; Aaltomaa S; Lipponen P; Isotalo T; Talja M; Mokka R
Anticancer Res; 2005; 25(6C):4435-8. PubMed ID: 16334122
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma.
Mäkelä J; Kiviniemi H; Laitinen S
Hepatogastroenterology; 2002; 49(46):971-5. PubMed ID: 12143256
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
Ropponen K; Tammi M; Parkkinen J; Eskelinen M; Tammi R; Lipponen P; Agren U; Alhava E; Kosma VM
Cancer Res; 1998 Jan; 58(2):342-7. PubMed ID: 9443415
[TBL] [Abstract][Full Text] [Related]
11. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
13. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer.
Wigmore SJ; McMahon AJ; Sturgeon CM; Fearon KC
Br J Surg; 2001 Feb; 88(2):255-60. PubMed ID: 11167877
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in colorectal adenocarcinoma].
Lagautrière F; Valvano L; Chaazl M; Benchimol D; Bernard JL; Bourgeon A; Richelme H
Ann Ital Chir; 1998; 69(4):491-6; discussion 496-7. PubMed ID: 9835125
[TBL] [Abstract][Full Text] [Related]
17. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytic infiltration surrounding liver metastases from colorectal cancer.
Okano K; Maeba T; Moroguchi A; Ishimura K; Karasawa Y; Izuishi K; Goda F; Usuki H; Wakabayashi H; Maeta H
J Surg Oncol; 2003 Jan; 82(1):28-33. PubMed ID: 12501166
[TBL] [Abstract][Full Text] [Related]
20. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
Yao HB; Wu AG; Chen YJ; Tang BH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
